Aspira Women’s Health Inc. SEC filings AWHL
Aspira Women’s Health Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Aug 12, 2011. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 15, 2026 (material agreement, new debt). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jul 15, 2026 | Jul 6, 2026 |
| 8-K/A |
Amended current report
Officer or director change
|
Jul 7, 2026 | Jun 17, 2026 |
| D | Filing | Jun 22, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Jun 22, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 9, 2026 | Jun 5, 2026 |
| DEFA14A | Additional proxy material | May 29, 2026 | — |
| 8-K |
Current report
Material agreement
|
May 26, 2026 | May 20, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 30, 2026 | Apr 26, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 24, 2026 | Jun 17, 2026 |
| 10-K | Annual report | Apr 1, 2026 | Dec 31, 2025 |
| NT 10-K | Filing | Apr 1, 2026 | Dec 31, 2025 |
| 8-K/A |
Amended current report
Material agreement
|
Mar 25, 2026 | Dec 23, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Jan 30, 2026 | Jan 30, 2026 |
| 424B3 | Prospectus | Jan 12, 2026 | — |
| EFFECT | Filing | Jan 9, 2026 | — |
| CORRESP | Letter to the SEC | Jan 7, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 6, 2026 | — |
| S-1 | Registration statement | Dec 31, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 31, 2025 | Dec 29, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 23, 2025 | Dec 23, 2025 |
| 8-K |
Current report
Material agreement
|
Dec 22, 2025 | Dec 16, 2025 |
| EFFECT | Filing | Nov 21, 2025 | — |
| 424B3 | Prospectus | Nov 21, 2025 | — |
| CORRESP | Letter to the SEC | Nov 19, 2025 | — |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2025 | Nov 14, 2025 |
| 8-K/A |
Amended current report
Material agreement, Unregistered share sale
|
Nov 3, 2025 | Sep 19, 2025 |
| S-1/A | Amended registration statement | Oct 20, 2025 | — |
| 8-K |
Current report
Other events
|
Oct 15, 2025 | Oct 14, 2025 |
| S-1 | Registration statement | Sep 30, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 25, 2025 | Sep 19, 2025 |
| D | Filing | Sep 18, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Sep 18, 2025 | Sep 16, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 3, 2025 | Sep 2, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 12, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 15, 2025 | Jul 11, 2025 |
| 8-K |
Current report
Other events
|
Jun 11, 2025 | Jun 11, 2025 |
| S-8 | Employee stock plan registration | Jun 9, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2025 | Jun 4, 2025 |
| 10-Q | Quarterly report | May 19, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 19, 2025 | May 19, 2025 |
| NT 10-Q | Filing | May 15, 2025 | Mar 31, 2025 |
| EFFECT | Filing | May 7, 2025 | — |
| 424B3 | Prospectus | May 7, 2025 | — |
| CORRESP | Letter to the SEC | May 6, 2025 | — |
| S-1/A | Amended registration statement | May 6, 2025 | — |
| CORRESP | Letter to the SEC | May 6, 2025 | — |
| S-1/A | Amended registration statement | May 1, 2025 | — |
| CORRESP | Letter to the SEC | Apr 30, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 22, 2025 | — |
| DEFR14A | Filing | Apr 22, 2025 | — |
| 8-K |
Current report
Listing notice
|
Apr 16, 2025 | Apr 15, 2025 |
| S-1 | Registration statement | Apr 16, 2025 | — |
| ARS | Annual report to shareholders | Apr 14, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 11, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
|
Apr 8, 2025 | Apr 2, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 31, 2025 | Mar 28, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 31, 2025 | Mar 27, 2025 |
| 10-K | Annual report | Mar 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 25, 2025 | Mar 21, 2025 |
| D | Filing | Mar 20, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Mar 19, 2025 | Mar 15, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Mar 11, 2025 | Mar 5, 2025 |
| 8-K |
Current report
Listing notice
|
Feb 14, 2025 | Feb 11, 2025 |
| RW | Filing | Feb 13, 2025 | — |
| S-1/A | Amended registration statement | Feb 11, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Feb 10, 2025 | Feb 5, 2025 |
| FWP | Free writing prospectus | Jan 31, 2025 | — |
| S-1/A | Amended registration statement | Jan 31, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Jan 31, 2025 | Jan 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| S-1 | Registration statement | Jan 8, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Jan 7, 2025 | Jan 6, 2025 |
| 8-K |
Current report
Listing notice
|
Dec 31, 2024 | Dec 31, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 16, 2024 | Dec 16, 2024 |
| 10-Q | Quarterly report | Nov 19, 2024 | Sep 30, 2024 |
| NT 10-Q | Filing | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 29, 2024 | Oct 29, 2024 |
| 8-K |
Current report
Other events
|
Oct 24, 2024 | Oct 24, 2024 |
| 8-K |
Current report
Other events
|
Oct 23, 2024 | Oct 23, 2024 |
| 8-K |
Current report
Listing notice
|
Oct 18, 2024 | Oct 17, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 13, 2024 | Sep 9, 2024 |
| 424B3 | Prospectus | Sep 5, 2024 | — |
| EFFECT | Filing | Sep 3, 2024 | — |
| CORRESP | Letter to the SEC | Aug 29, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 28, 2024 | — |
| S-3 | Shelf registration | Aug 23, 2024 | — |
| S-8 | Employee stock plan registration | Aug 20, 2024 | — |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Material agreement
|
Aug 2, 2024 | Aug 2, 2024 |
| 424B5 | Prospectus supplement | Aug 2, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 31, 2024 | Jul 31, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 29, 2024 | Jul 25, 2024 |
| 424B3 | Prospectus | Jul 25, 2024 | — |
| EFFECT | Filing | Jul 24, 2024 | — |
| CORRESP | Letter to the SEC | Jul 23, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 22, 2024 | — |
| S-3 | Shelf registration | Jul 17, 2024 | — |
| D | Filing | Jul 12, 2024 | — |
| 8-K |
Current report
Listing notice
|
Jul 5, 2024 | Jul 1, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 2, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 27, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 14, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 7, 2024 | Jun 6, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 14, 2024 | May 13, 2024 |
| DEFA14A | Additional proxy material | May 10, 2024 | — |
| 8-K |
Current report
Other events
|
Apr 26, 2024 | Apr 26, 2024 |
| 424B5 | Prospectus supplement | Apr 26, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Apr 26, 2024 | Apr 22, 2024 |
| EFFECT | Filing | Apr 25, 2024 | — |
| CORRESP | Letter to the SEC | Apr 24, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 23, 2024 | — |
| S-3 | Shelf registration | Apr 22, 2024 | — |
| EFFECT | Filing | Apr 11, 2024 | — |
| 424B3 | Prospectus | Apr 11, 2024 | — |
| CORRESP | Letter to the SEC | Apr 10, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 9, 2024 | — |
| S-1 | Registration statement | Apr 5, 2024 | — |
| ARS | Annual report to shareholders | Apr 1, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 1, 2024 | — |
| DEF 14A | Proxy statement | Apr 1, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Apr 1, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 25, 2024 | Mar 20, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 21, 2024 | Mar 16, 2024 |
| D | Filing | Feb 7, 2024 | — |
| S-8 | Employee stock plan registration | Jan 26, 2024 | — |
| 8-K/A |
Amended current report
Material agreement, Results of operations, Unregistered share sale, Change to shareholder rights
|
Jan 26, 2024 | Jan 24, 2024 |
| 424B5 | Prospectus supplement | Jan 26, 2024 | — |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Change to shareholder rights
|
Jan 25, 2024 | Jan 24, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 5, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 27, 2023 | Dec 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 6, 2023 | Dec 6, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 10-K/A | Amended annual report | Oct 26, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Other events
|
Oct 23, 2023 | Oct 23, 2023 |
| 8-K |
Current report
Restatement
|
Oct 13, 2023 | Oct 13, 2023 |
| 8-K |
Current report
Other events
|
Sep 13, 2023 | Sep 12, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 12, 2023 | Sep 7, 2023 |
| 8-K/A |
Amended current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 9, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Material agreement
|
Jul 24, 2023 | Jul 20, 2023 |
| 424B5 | Prospectus supplement | Jul 24, 2023 | — |
| 8-K |
Current report
Other events
|
Jul 20, 2023 | Jul 19, 2023 |
| 8-K |
Current report
Listing notice
|
Jul 14, 2023 | Jul 11, 2023 |
| 8-K |
Current report
Other events
|
Jun 28, 2023 | Jun 26, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Jun 2, 2023 | May 26, 2023 |
| 8-K |
Current report
Officer or director change
|
May 16, 2023 | May 16, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 10, 2023 | May 9, 2023 |
| 8-K |
Current report
Results of operations
|
Apr 28, 2023 | Apr 27, 2023 |
| ARS | Annual report to shareholders | Apr 4, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 4, 2023 | — |
| DEF 14A | Proxy statement | Mar 30, 2023 | — |
| 10-K | Annual report | Mar 30, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Material agreement
|
Mar 30, 2023 | Mar 28, 2023 |
| 424B5 | Prospectus supplement | Mar 29, 2023 | — |
| 8-K |
Current report
Results of operations
|
Mar 22, 2023 | Mar 22, 2023 |
| PRE 14A | Preliminary proxy statement | Mar 20, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 13, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 3, 2023 | Feb 28, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 2, 2023 | Mar 1, 2023 |
| 8-K |
Current report
Other events
|
Feb 10, 2023 | Feb 10, 2023 |
| 424B5 | Prospectus supplement | Feb 10, 2023 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Feb 7, 2023 | Feb 6, 2023 |
| 8-K/A |
Amended current report
Regulation FD disclosure
|
Jan 10, 2023 | Jan 10, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2023 | Jan 10, 2023 |
| 8-K |
Current report
Results of operations
|
Jan 9, 2023 | Jan 9, 2023 |
| DEF 14A | Proxy statement | Dec 28, 2022 | Dec 28, 2022 |
| PRER14A | Filing | Dec 28, 2022 | — |
| 8-K/A |
Amended current report
Officer or director change
|
Dec 22, 2022 | Dec 15, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 21, 2022 | Dec 15, 2022 |
| PRE 14A | Preliminary proxy statement | Dec 16, 2022 | Dec 16, 2022 |
| 8-K |
Current report
Listing notice
|
Dec 2, 2022 | Nov 29, 2022 |
| 8-K |
Current report
Officer or director change
|
Nov 30, 2022 | Nov 28, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Other events
|
Aug 24, 2022 | Aug 22, 2022 |
| 424B5 | Prospectus supplement | Aug 24, 2022 | — |
| 424B5 | Prospectus supplement | Aug 22, 2022 | — |
| 10-Q | Quarterly report | Aug 10, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2022 | Aug 10, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 27, 2022 | Jun 23, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- AWHL (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Austin, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 926617
- Former names
- VERMILLION, INC. (until Jun 10, 2020); CIPHERGEN BIOSYSTEMS INC (until Aug 17, 2007)
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Neogen Corp NEOG
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Achieve Life Sciences, Inc. ACHV
- Myriad Genetics Inc MYGN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.